Biomedical researchers have designed an injectable microgel to help reduce bleeding in infants who require surgical care. In an animal model, the engineered microgel reduced bleeding by at least 50%. The paper, “Hemostatic B-Knob Triggered MicroGels (BK-TriGs) to Address Bleeding in Neonates,” is published in the journal Science Advances.
Ovarian cancer remains the deadliest gynecologic cancer, largely because it is rarely found early. Symptoms are often vague, and existing screening approaches—such as blood tests and transvaginal ultrasound—can miss the disease at stages when treatment is most effective. In recent years, research has reshaped understanding of how many aggressive ovarian cancers begin, pointing not to the ovary itself, but to the fallopian tubes. That shift has created a need for tools that can safely examine these narrow structures for early changes linked to cancer.
Garmin users can now integrate with the temperature-powered Natural Cycles app, which turns Garmin skin temperature data into fertility insights for women’s health
Butterfly’s GA tool within its point-of-care ultrasound (POCUS) system is intended for rollout in regions with socioeconomic barriers to obstetric imaging services.
Researchers from the Technion—Israel Institute of Technology, together with collaborators from leading medical centers in the United States and Europe, have developed an artificial intelligence (AI) model that predicts both the risk of breast cancer recurrence and the likelihood that a patient will benefit from chemotherapy.
Scientists at the University of Utah (the U) have developed a new “lab-on-a-chip” device that uses artificial intelligence to rapidly predict cancer cell sensitivity to targeted therapies for children with T-cell acute lymphoblastic leukemia (T-ALL), an aggressive and difficult-to-treat cancer.
MOUNTAIN LAKES, N.J., March 24, 2026 /PRNewswire/ — LiviWell, a women’s health company dedicated to developing innovative solutions for intimate health, today announced that the U.S. Food and Drug Administration (FDA) has cleared Livi, a first-of-its-kind device designed to support vaginal health by absorbing semen and other post-intercourse fluids.
CINCINNATI, March 18, 2026 /PRNewswire/ — Mammotome, a Danaher company, announces FDA Clearance of two innovations for MR-guided breast biopsy: the Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System – the industry’s first solution designed to be positioned in the MRI scanner room at the patient’s side – and the HydroMARK™ Plus Breast Biopsy Site Marker for MR, engineered for exclusive use with the Mammotome Prima™ system universal targeting set. Following a successful debut of the Mammotome Prima™ MR system in Europe, both products will be introduced to U.S. clinicians at the 2026 Society of Breast Imaging (SBI) Symposium. By bringing the device directly into the scanner room, the Mammotome Prima™ MR system enhances clinician coordination, streamlines communication, and helps maintain consistent focus on the patient throughout the procedure.
From cobblers to smoothies, dark sweet cherries show up in plenty of recipes, and scientists say the crimson-colored fruit may contain compounds that could help fight an aggressive type of breast cancer.
Researchers at Mass General Brigham have developed a series of artificial intelligence (AI) tools that uses machine learning to identify individuals who may be at risk for intimate partner violence (IPV) using information from their electronic medical records (EMRs).